
|Articles|July 31, 2017
- July 2017 Digestive Health
- Volume 83
- Issue 7
Can You Read These Rxs? (July 2017)
Can you figure out what these prescriptions say?
Advertisement
Send in your eye-straining, baffling prescriptions—now via e-mail and fax as well as regular mail! Submissions must include a clean photocopy or scanned image of the Rx; your institution’s name and location; your name and title; the correct name of the drug(s), strength, and dosing requirements; and your phone number. You can e-mail scanned Rxs to rmarotta@pharmacytimes.com; fax them to 609-257-0701; or mail them to Can You Read These Rxs?, Pharmacy Times, 2 Clarke Drive, Suite 100, Cranbury, NJ 08512.
Articles in this issue
about 9 years ago
Rx Product News (July 2017)about 9 years ago
Leg Cramps: A Sign of Underlying Illness?about 9 years ago
Self-Care for Digestive Healthabout 9 years ago
Drug Diversion and Veterinariansabout 9 years ago
Lipid Management for Patients With Diabetesabout 9 years ago
Case Studies (July 2017)about 9 years ago
Pet Peeves (July 2017)about 9 years ago
2017 Technology Innovator of the Year FinalistsAdvertisement
Related to this article

A current pharmacy resident provides insights on how pharmacy students can manage the transition from student to resident.

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.

Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.

The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Two recent graduates share strategies for standing out in the competitive fellowship application process.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Talazoparib With Enzalutamide for HRR-Mutated Metastatic Prostate Cancer
2
Medicare GLP-1 Bridge Runs Outside Part D and Pharmacy Teams Need a Different Workflow
3
Beyond Prescription Volume: Measuring the Pharmacist’s Value
4
GLP-1 RAs, Finerenone, and CKD: Key Data From Kidney Week 2026
5


